Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary Group

  1. García-del-Muro, X.
  2. Durán, I.
  3. Perez-Gracia, J.L.
  4. Ángel Climent, M.
  5. Mellado, B.
  6. Virizuela, J.A.
  7. Castellano, D.E.
  8. González del Alba, A.
  9. García Carbonero, I.
  10. Álvarez-Fernández, C.
  11. García-Donas, J.
  12. Gil-Martin, M.
  13. Hernández, A.-G.
Revue:
Clinical Genitourinary Cancer

ISSN: 1938-0682 1558-7673

Année de publication: 2022

Volumen: 20

Número: 4

Pages: 388.e1-388.e10

Type: Article

DOI: 10.1016/J.CLGC.2022.03.008 GOOGLE SCHOLAR

Objectifs de Développement Durable